Literature DB >> 14715377

The implications of 7-dehydrosterol-7-reductase deficiency (Smith-Lemli-Opitz syndrome) to neurosteroid production.

Josep Marcos1, Li-Wei Guo, William K Wilson, Forbes D Porter, Cedric Shackleton.   

Abstract

Smith-Lemli-Opitz syndrome (SLOS) is an autosomal recessive, multiple malformation/mental retardation syndrome with an estimated incidence among individuals of European ancestry of 1 in 20000 to 1 in 30000. It is caused by inactivity of the enzyme 7-dehydrosterol-delta(7)-reductase, which catalyses the terminal transformation in cholesterol synthesis. Patients show not only an increased level of 7-dehydrocholesterol in blood and tissues, but also increased 8-dehydrocholesterol because of the presence of an active delta(8)-delta(7) isomerase. A major consequence of these biochemical abnormalities is the alteration of normal embryonic and fetal somatic development causing postnatal abnormalities of growth, learning, language and behavior. While deficient cholesterol during early development is the primary cause of central nervous system (CNS) abnormalities and retardation, we questioned whether neurosteroids could also be involved since they can have a profound influence on behavioral characteristics. Disordered neurosteroidogenesis would be expected in SLOS and could be caused by a deficiency in classical neurosteroid synthesis secondary to cholesterol deficiency, or by synthesis from 7- and 8-dehydrocholesterol of novel neurosteroids with delta(7) or delta(8) unsaturation which may have altered activity compared with conventional neurosteroids. In particular we sought analogues of dehydroepiandrosterone sulfate, pregnenolone sulfate and the pregnanolone epimers. We targeted urine from post-pubertal females, as this type of sample would be most likely to yield identifiable amounts of the pregnanolone metabolites of progesterone. Analysis by GC/MS of urinary steroids excreted by post-pubertal females confirmed the presence of neurosteroid-like compounds in SLOS patient's urine. Even though the new neuroactive steroids identified were unlikely to have been formed in the brain, it is likely that mechanisms for their synthesis are operable in this organ.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14715377     DOI: 10.1016/j.steroids.2003.09.013

Source DB:  PubMed          Journal:  Steroids        ISSN: 0039-128X            Impact factor:   2.668


  23 in total

Review 1.  Malformation syndromes caused by disorders of cholesterol synthesis.

Authors:  Forbes D Porter; Gail E Herman
Journal:  J Lipid Res       Date:  2010-10-07       Impact factor: 5.922

2.  Synthesis and photochemical transformation of 3β,21-dihydroxypregna-5,7-dien-20-one to novel secosteroids that show anti-melanoma activity.

Authors:  Michal A Zmijewski; Wei Li; Jianjun Chen; Tae-Kang Kim; Jordan K Zjawiony; Trevor W Sweatman; Duane D Miller; Andrzej T Slominski
Journal:  Steroids       Date:  2010-11-09       Impact factor: 2.668

Review 3.  Neuroendocrine system of the skin.

Authors:  Andrzej Slominski
Journal:  Dermatology       Date:  2005       Impact factor: 5.366

Review 4.  The role of CYP11A1 in the production of vitamin D metabolites and their role in the regulation of epidermal functions.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Wei Li; Ae-Kyung Yi; Arnold Postlethwaite; Robert C Tuckey
Journal:  J Steroid Biochem Mol Biol       Date:  2013-10-28       Impact factor: 4.292

Review 5.  Recent insights into the Smith-Lemli-Opitz syndrome.

Authors:  H Yu; S B Patel
Journal:  Clin Genet       Date:  2005-11       Impact factor: 4.438

6.  A new steroidal 5,7-diene derivative, 3beta-hydroxyandrosta-5,7-diene-17beta-carboxylic acid, shows potent anti-proliferative activity.

Authors:  Tae-Kang Kim; Jianjun Chen; Wei Li; Jordan Zjawiony; Duane Miller; Zorica Janjetovic; Robert C Tuckey; Andrzej Slominski
Journal:  Steroids       Date:  2009-12-16       Impact factor: 2.668

7.  Cytochrome P450scc-dependent metabolism of 7-dehydrocholesterol in placenta and epidermal keratinocytes.

Authors:  Andrzej T Slominski; Tae-Kang Kim; Jianjun Chen; Minh N Nguyen; Wei Li; Charles R Yates; Trevor Sweatman; Zorica Janjetovic; Robert C Tuckey
Journal:  Int J Biochem Cell Biol       Date:  2012-08-02       Impact factor: 5.085

8.  Disorders of cholesterol metabolism and their unanticipated convergent mechanisms of disease.

Authors:  Frances M Platt; Christopher Wassif; Alexandria Colaco; Andrea Dardis; Emyr Lloyd-Evans; Bruno Bembi; Forbes D Porter
Journal:  Annu Rev Genomics Hum Genet       Date:  2014       Impact factor: 8.929

9.  Molecular consequences of altered neuronal cholesterol biosynthesis.

Authors:  Zeljka Korade; Anne K Kenworthy; Károly Mirnics
Journal:  J Neurosci Res       Date:  2009-03       Impact factor: 4.164

10.  Analysis of short-term behavioral effects of dietary cholesterol supplementation in Smith-Lemli-Opitz syndrome.

Authors:  Elaine Tierney; Sandra K Conley; Halima Goodwin; Forbes D Porter
Journal:  Am J Med Genet A       Date:  2010-01       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.